Fortrea Holdings Inc. ( FTRE) - Key Metrics
FTRE Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $7.19 | -$0.14 | -$0.18 | -$0.27 |
| 2026Q1 | $6.98 | -$0.26 | -$0.19 | -$0.27 |
| 2025Q4 | $7.24 | -$0.36 | $1.42 | $1.33 |
| 2025Q3 | $7.69 | -$0.17 | $0.95 | $0.87 |
| 2025Q2 | $7.84 | -$4.14 | $0.24 | $0.16 |
FTRE Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -31.07 |
| 2026Q1 | 0% | -9.06 |
| 2025Q4 | 0% | -11.98 |
| 2025Q3 | 0% | -12.38 |
| 2025Q2 | 0% | -0.30 |
FTRE
Price: $22.74
52 week price:
Earnings Per Share: -0.83 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 1.9 billion